Literature DB >> 3077086

Effects of beta-lactams on DNA replication.

U Hübscher1, U D Huynh, M Hässig, K A Neftel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3077086     DOI: 10.1007/bf00117856

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


× No keyword cloud information.
  12 in total

1.  The delta subunit of Escherichia coli DNA polymerase III holoenzyme is the dnaX gene product.

Authors:  U Hübscher; A Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

Review 2.  Beta-lactam antibiotics inhibit human in vitro granulopoiesis and proliferation of some other cell types.

Authors:  K A Neftel; M R Müller; U Widmer; A W Hügin
Journal:  Cell Biol Toxicol       Date:  1986-12       Impact factor: 6.691

3.  Enzymatic breakage of deoxyribonucleic acid. II. Purification and properties of endonuclease IV from T4 phage-infected Escherichia coli.

Authors:  P D Sadowski; J Hurwitz
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

4.  A DNA primase activity associated with DNA polymerase alpha from Drosophila melanogaster embryos.

Authors:  R C Conaway; I R Lehman
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

5.  Functional roles of DNA polymerases beta and gamma.

Authors:  U Hübscher; C C Kuenzle; S Spadari
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

6.  Suppressive effects of B-lactam-antibiotics on in vitro generation of cytotoxic T-cells.

Authors:  A W Huegin; A Cerny; R M Zinkernagel; K A Neftel
Journal:  Int J Immunopharmacol       Date:  1986

7.  Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics.

Authors:  K A Neftel; S P Hauser; M R Müller
Journal:  J Infect Dis       Date:  1985-07       Impact factor: 5.226

8.  DNA polymerase beta from brain neurons is a repair enzyme.

Authors:  J Waser; U Hübscher; C C Kuenzle; S Spadari
Journal:  Eur J Biochem       Date:  1979-07

9.  The mammalian primase is part of a high molecular weight DNA polymerase alpha polypeptide.

Authors:  U Hübscher
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  A mammalian DNA polymerase alpha holoenzyme functioning on defined in vivo-like templates.

Authors:  U Hübscher; P Gerschwiler; G K McMaster
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  9 in total

1.  The prophylactic use of antibiotics in cell culture.

Authors:  I Kuhlmann
Journal:  Cytotechnology       Date:  1995-06       Impact factor: 2.058

2.  Betalactam antibiotics interfere with eukaryotic DNA-replication by inhibiting DNA polymerase alpha.

Authors:  U H Do; K A Neftel; S Spadari; U Hübscher
Journal:  Nucleic Acids Res       Date:  1987-12-23       Impact factor: 16.971

Review 3.  A comparison of the effects of cytosine arabinoside and beta-lactams on DNA synthesis and cellular proliferation.

Authors:  R J Fram
Journal:  Cell Biol Toxicol       Date:  1986-12       Impact factor: 6.691

4.  Effects of beta-lactam antibiotics on eukaryotic cells.

Authors:  J M Dewdney
Journal:  Cell Biol Toxicol       Date:  1986-12       Impact factor: 6.691

Review 5.  Effects of beta-lactam antibiotics on proliferating eucaryotic cells.

Authors:  K A Neftel; U Hübscher
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

Review 6.  [Evaluation of hematologic side effects of anti-infective therapy: agranulocytosis caused by beta-lactam antibiotics, vancomycin and amodiaquine].

Authors:  G Eich; K A Neftel
Journal:  Infection       Date:  1991       Impact factor: 3.553

7.  HP 0.35, a cephalosporin degradation product is a specific inhibitor of lentiviral RNAses H.

Authors:  P Hafkemeyer; K Neftel; R Hobi; A Pfaltz; H Lutz; K Lüthi; F Focher; S Spadari; U Hübscher
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

8.  Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells.

Authors:  Gulcin Tezcan; Mohammad Alsaadi; Shaimaa Hamza; Ekaterina E Garanina; Ekaterina V Martynova; Gulshat R Ziganshina; Elina R Farukshina; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  Int J Mol Sci       Date:  2022-08-22       Impact factor: 6.208

Review 9.  Setting the Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a Floor or Even a Ceiling?

Authors:  Erin F Barreto; Andrew J Webb; Gwendolyn M Pais; Andrew D Rule; Paul J Jannetto; Marc H Scheetz
Journal:  Crit Care Explor       Date:  2021-06-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.